The Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant markups. Justices Vikram Nath and SVN Bhatti criticized pharma companies for neglecting the struggles of ordinary people. They urged the government to consider a uniform pricing rule that limits maximum retail prices. The court highlighted the burden on taxpayers due to inflated medical expenses reimbursed under public health schemes.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.